Showing results (1-10 of 280) with videos related to
Sort By:
Pageof 28
Current Opinion in Immunology|October 1, 1994
Recent developments in immunotoxin therapyM A Ghetie, E S VitettaBlood|February 27, 2001
Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxinM A Ghetie, H Bright, E S VitettaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cellsM A Ghetie, V Ghetie, E S VitettaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
The combined use of an immunotoxin and a radioimmunoconjugate to treat disseminated human B-cell lymphoma in immunodeficient miceB R Wei, M A Ghetie, E S VitettaCancer Research|March 1, 1991
Covalent binding of human alpha 2-macroglobulin to deglycosylated ricin A chain and its immunotoxinsM A Ghetie, J W Uhr, E S VitettaJournal of Immunological Methods|September 13, 1988
Large scale preparation of immunotoxins constructed with the Fab' fragment of IgG1 murine monoclonal antibodies and chemically deglycosylated ricin A chainV Ghetie, M A Ghetie, J W Uhr, et al.Laboratory Animal Science|June 1, 1996
Effect of sublethal irradiation of SCID mice on growth of B-cell lymphoma xenografts and on efficacy of chemotherapy and/or immunotoxin therapyM A Ghetie, B E Gordon, E M Podar, et al.Blood|November 1, 1992
The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxinM A Ghetie, K Tucker, J Richardson, et al.Blood|August 1, 1994
Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktailM A Ghetie, K Tucker, J Richardson, et al.Journal of Immunological Methods|January 24, 1990
Large scale preparation of an immunoconjugate constructed with human recombinant CD4 and deglycosylated ricin A chainV Ghetie, M A Till, M A Ghetie, et al.Pageof 28